end of compounded semaglutide Hims & Hers stock falls 25% as FDA curtails GLP-1s Compounded Semaglutide: Safety & Regulation

Its hard when you speak in absolutes, because the truth is probably somewhere in the middle, said Gina Moore, PharmD, MBA, associate professor of the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

Proper handling and storage are critical for maintaining peptide integrity and ensuring reproducible research results

In the future, Retatrutide may be considered for individuals who meet specific health criteria, such as those living with obesity or weight-related conditions, but suitability would depend on personal medical factors

The IRS classifies GLP-1 receptor agonists as qualifying medical expenses when prescribed by a licensed healthcare provider for weight management

Mertins P., Mani D

And if you're considering whether medication might be right for you, talk with your healthcare provider about all your options